# ENSACOVE
> **NDA218171** · New Drug Application · Sponsor: XCOVERY · Approved 2024-12-18
## Drug
- **FDA Application Number:** NDA218171
- **Application type:** New Drug Application
- **Brand name:** ENSACOVE
- **Generic name:** ENSARTINIB
- **Active ingredients:** ENSARTINIB HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** XCOVERY
- **Manufacturer:** Xcovery Holdings, Inc.
- **First approval:** 2024-12-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218171)
---
*AI Analytics · CC0 1.0*